Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19

Detalles Bibliográficos
Autores principales: Zhang, Quan, Ye, Zhan, Bignotti, Antonia, Zheng, X. Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665299/
http://dx.doi.org/10.1182/blood-2022-163715
_version_ 1784831261613752320
author Zhang, Quan
Ye, Zhan
Bignotti, Antonia
Zheng, X. Long
author_facet Zhang, Quan
Ye, Zhan
Bignotti, Antonia
Zheng, X. Long
author_sort Zhang, Quan
collection PubMed
description
format Online
Article
Text
id pubmed-9665299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652992022-11-16 Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19 Zhang, Quan Ye, Zhan Bignotti, Antonia Zheng, X. Long Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665299/ http://dx.doi.org/10.1182/blood-2022-163715 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Abstracts
Zhang, Quan
Ye, Zhan
Bignotti, Antonia
Zheng, X. Long
Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
title Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
title_full Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
title_fullStr Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
title_full_unstemmed Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
title_short Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
title_sort elevated plasma levels of von willebrand factor and syndecan-1 predict 60-day mortality in patients with severe and critical covid-19
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665299/
http://dx.doi.org/10.1182/blood-2022-163715
work_keys_str_mv AT zhangquan elevatedplasmalevelsofvonwillebrandfactorandsyndecan1predict60daymortalityinpatientswithsevereandcriticalcovid19
AT yezhan elevatedplasmalevelsofvonwillebrandfactorandsyndecan1predict60daymortalityinpatientswithsevereandcriticalcovid19
AT bignottiantonia elevatedplasmalevelsofvonwillebrandfactorandsyndecan1predict60daymortalityinpatientswithsevereandcriticalcovid19
AT zhengxlong elevatedplasmalevelsofvonwillebrandfactorandsyndecan1predict60daymortalityinpatientswithsevereandcriticalcovid19

Ejemplares similares